截至今日:Aug 21, 09:59:34 GMT-4
No Data Yet
Moderna shares surged as much as 177% after its personalized cancer vaccine met both Phase 3 melanoma trial endpoints, with Bank of America upgrading the stock.
Big Pharma is shifting from mega-mergers to smaller bolt-on deals, with 24 acquisitions under $3 billion in 2026, as investors reward disciplined dealmaking.
US stocks close higher as Treasury Department expands buyback program for longer-term bonds, easing pressure on yields.
Merck & Co. shares rose 10% to an all-time high, lifting the drugmaker's market value to $366.9 billion.
Merck & Co Inc 的市盈率是 18.0537
Mr. Robert Davis 是 Merck & Co Inc 的 Chairman of the Board,自 2014 加入公司。
MRK 的当前价格为 $148.6,在上个交易日 下降 了 2.36%。
Merck & Co Inc 属于 Pharmaceuticals 行业,该板块是 Health Care
Merck & Co Inc 的当前市值是 $367.0B
据华尔街分析师称,共有 31 位分析师对 Merck & Co Inc 进行了分析师评级,包括 7 位强烈买入,12 位买入,14 位持有,0 位卖出,以及 7 位强烈卖出